Global Registry for Endovascular Aortic Treatment (GREAT)

Active, not recruitingOBSERVATIONAL
Enrollment

4,600

Participants

Timeline

Start Date

December 31, 2010

Primary Completion Date

June 30, 2027

Study Completion Date

June 30, 2027

Conditions
Multiple Pathologies
Interventions
DEVICE

Endovascular aortic repair

Treatment with Gore Endovascular Aortic Products.

Trial Locations (6)

60637

The University of Chicago Medicine & Biological Sciences, Chicago

Unknown

Baylor Research Institute, Plano

Royal Prince Alfred Hospital, Camperdown

Coris Medicina Avançada, Florianópolis

Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico, Milan

IRCCS Policlinico San Donato, Milan

All Listed Sponsors
lead

W.L.Gore & Associates

INDUSTRY

NCT01658787 - Global Registry for Endovascular Aortic Treatment (GREAT) | Biotech Hunter | Biotech Hunter